Treatment of Waldenstrom's macroglobulinemia with rituximab: prognostic factors for response and progression.
Dimopoulos MA, Alexanian R, Gika D, Anagnostopoulos A, Zervas C, Zomas A, Kyrtsonis MC, Anagnostopoulos N, Pangalis GA, Weber DM.
Dimopoulos MA, et al. Among authors: anagnostopoulos n, anagnostopoulos a.
Leuk Lymphoma. 2004 Oct;45(10):2057-61. doi: 10.1080/10428190410001723287.
Leuk Lymphoma. 2004.
PMID: 15370250
Clinical Trial.